Acylated indanyl amines and their use as pharmaceuticals
Details for Australian Patent Application No. 2002253010 (hide)
International Classifications
Event Publications
20 February 2003 Application Open to Public Inspection
Published as AU-B-2002253010
25 September 2003 Amendment Made
The nature of the amendment is: Add the co-inventor Schoenafinger, Karl
22 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
28 February 2008 Application Accepted
Published as AU-B-2002253010
26 June 2008 Standard Patent Sealed
2 April 2009 Corrigenda
Applications Accepted - Name Index Under the name Sanofi-Aventis Deutschland GmbH, Application No. 2002253010, under INID (72) correct the co-inventor name to read Walser, Armin.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002253009-4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser